What is Ocala Kidney Group?
Established in 1984, Ocala Kidney Group operates as a premier healthcare provider dedicated to the comprehensive management of chronic kidney disease, dialysis, and transplant services. With a team of eleven board-certified nephrologists, the practice serves as a cornerstone of renal health in its region. The firm distinguishes itself through evidence-based clinical protocols and a robust 24/7 support model, ensuring that patients receive continuous care across local hospitals and specialized dialysis units. Their market position is defined by decades of clinical excellence and a deep-rooted presence in the Florida healthcare landscape.
How much funding has Ocala Kidney Group raised?
Ocala Kidney Group has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Ocala Kidney Group
PPP
Public-Private Partnership
What's next for Ocala Kidney Group?
With this recent capital injection, Ocala Kidney Group is well-positioned to scale its infrastructure and modernize its patient care delivery systems. The strategic focus will likely shift toward integrating advanced diagnostic technologies and expanding the reach of its dialysis facilities to meet the growing demand for specialized nephrology services. As the organization navigates the complexities of the modern healthcare environment, this financial support provides the necessary runway to sustain its high-quality care standards while exploring potential growth opportunities in adjacent medical markets. The firm remains focused on long-term sustainability and the continued improvement of patient outcomes through clinical innovation.
See full Ocala Kidney Group company page
